1-9 of 9
Fanny Baran-Marszak, MD
Close
Sort by
Journal Articles

IKZF3 Overexpression Phenocopies Gain-of-Function Mutation in Chronic Lymphocytic Leukemia

Shanye Yin, PhD, Gregory Lazarian, PharmD, Elisa Ten Hacken, PhD, Tomasz Sewastianik, PhD, Satyen Gohil, BSc, MBBS, MRCP, FRCPath, Shuqiang Li, PhD, Laura Z. Rassenti, PhD, Leah Billington, BA, Elizabeth Witten, Teddy Huang, BS, Kenneth J. Livak, PhD, Donna S. Neuberg, ScD, Fanny Baran-Marszak, MD PhD, Thomas J. Kipps, MD PhD, Florence Cymbalista, MD PhD, Ruben D. Carrasco, MD PhD, Catherine J. Wu, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 9.
https://doi.org/10.1182/blood-2020-137085
Published: 2020
Journal Articles

The Broad Spectrum of TP53 Variants in CLL: NGS Analysis of 573 Pathogenic TP53 Variants

Gregory Lazarian, PharmD, Floriane Theves, Myriam Hormi, Virginie Eclache, Stéphanie Poulain, MD, Audrey Bidet, Cedric Pastoret, MD, Lauren Veronese, MD PhD, Eric Delabesse, MD PhD, Marie-Hélène Estienne, Nathalie Nadal, Frederic Davi, MD PhD, Florence Nguyen-Khac, MD PhD, Laurence Lode, Pierre Sujobert, MD PhD, Dina Naguib, MD, Sophie Raynaud, Stephane Giraudier, MD PhD, Olivier Kosmider, PharmD, PhD, Pascaline Etancelin, Pascale Cornillet-Lefebvre, Laurent Miguet, DPhil, Veronique Leblond, MD PhD, Remi Letestu, Thierry Soussi, Florence Cymbalista, MD PhD, Fanny Baran-Marszak, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 3021.
https://doi.org/10.1182/blood-2019-130907
Published: 2019
Journal Articles

High Prevalence of BTK Mutations on Ibrutinib Therapy after 3 Years of Treatment in a Real-Life Cohort of CLL Patients: A Study from the French Innovative Leukemia Organization (FILO) Group

Anne Quinquenel, Luc Matthieu Fornecker, Remi Letestu, Carole Fleury, Loic Ysebaert, MD PhD, Marie-Sarah Dilhuydy, MD, Romain Guieze, MD, Pierre Feugier, Damien Roos-Weil, MD, Lise Willems, MD, Anne-Sophie Michallet, MD PhD, Alain Jacques Delmer, MD, Pietro Taverna, PhD, Judith A. Fox, PhD, Vincent Levy, MD PhD, Florence Cymbalista, MD, Fanny Baran-Marszak, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 584.
https://doi.org/10.1182/blood-2018-99-114027
Published: 2018
Journal Articles

A Retrospective Analysis of 450 TP53 Mutations in a Real Life Cohort of CLL from the French Innovative Leukemia Organization (FILO) Group

Fanny Baran-Marszak, MD PhD, Valerie Vidal, Myriam Hormi, Virginie Eclache, Lauren Veronese, MD PhD, Olivier Tournilhac, MD PhD, Frederic Davi, Florence Nguyen-Khac, MD PhD, Veronique Leblond, Eric Delabesse, MD PhD, Loic Ysebaert, MD PhD, Audrey Bidet, PharmD, Marie-Sarah Dilhuydy, MD, Stephanie Poulain, MD PhD, Charles Herbaux, Marie-Helene Estienne, PharmD, Caroline Dartigeas, Cedric Pastoret, MD, Sophie de Guibert, Stephane Giraudier, MD PhD, Jehan Dupuis, MD, Pascale Cornillet-Lefebvre, Anne Quinquenel, Sophy Laibe, Thérèse Aurran, MD, Dina Naguib, MD MASTERS, Xavier Troussard, MD, Pierre Sujobert, MD PhD, Anne-Sophie Michallet, MD PhD, Catherine Thieblemont, MD PhD, Remi Letestu, Gregory Lazarian, PharmD, Vincent Levy, MD PhD, Thierry Soussi, Sophie Raynaud, MD PhD, Florence Cymbalista, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1722.
https://doi.org/10.1182/blood.V130.Suppl_1.1722.1722
Published: 2017
Journal Articles

Old DAT / New Data : Positive Direct Antiglobulin Test Identifies a Specific Subgroup Of CLL Patients

Anne Quinquenel, MD, Chadi Al Nawakil, MD, Fanny Baran-Marszak, MD, Virginie Eclache, MD, Remi Letestu, MD, Christine Le Roy, PhD, Nadine Varin-Blank, PhD, Alain Delmer, MD, Vincent Levy, MD, PhD, Florence Cymbalista, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 4154.
https://doi.org/10.1182/blood.V122.21.4154.4154
Published: 2013
Journal Articles

Abnormal Expression and Function of the Lnk Adaptor Protein in Myeloproliferative Neoplasms (MPN).

Jean-Jacques Kiladjian, MD, PhD, Fanny Baran-Marszak, MD, PhD, Christophe Desterke, PhD, Bruno Cassinat, Pharm.D, Hajer Magdoud, Elisabeth Mazoyer, MD, Pierre Fenaux, MD, PhD, Claude Gardin, Florence Cymbalista, MD, PhD, Marie-Caroline Le Bousse-Kerdiles, PhD, Nadine Varin-Blank, PhD, Laura Velazquez, PhD
Journal: Blood
Blood (2009) 114 (22): 2897.
https://doi.org/10.1182/blood.V114.22.2897.2897
Published: 2009
Journal Articles

CXCR4 and CD62L Down-Regulation Following B-Cell Receptor Ligation Is Restricted to Progressive Chronic Lymphocytic Leukemia (CLL) Cases.

Amalia Vlad, MD, Pierre-Antoine Deglesne, PhD, Remi Letestu, MD, Nathalie Chevallier, PhD, Fanny Baran-Marszak, MD, Nadine Varin-Blank, PhD, Florence Cymbalista, MD, Dominique Ledoux, PhD
Journal: Blood
Blood (2007) 110 (11): 1122.
https://doi.org/10.1182/blood.V110.11.1122.1122
Published: 2007
Journal Articles

Activation of NFAT and NFkB Transcription Factors upon B Cell Receptor (BCR) Stimulation Is Restricted to Evolutive Chronic Lymphocytic Leukemia (CLL) Cases.

Nathalie S. Chevallier, PhD, Pierre-Antoine Deglesne, PhD, Taoufik Beitar, Fanny Baran-Marszak, MD, Remi Letestu, MD, Amalia Vlad, MD, Valerie Lefebvre, Isabelle Clavereau, Florence Cymbalista, MD, Nadine Varin-Blank, PhD
Journal: Blood
Blood (2006) 108 (11): 2803.
https://doi.org/10.1182/blood.V108.11.2803.2803
Published: 2006
Journal Articles

Antitumor Genotoxic Agents, Such as Fludarabine*, Doxorubincin or Cis-Platine, Induce Activation of STAT1 in a p53 Protein Dependent Manner.

Ibtissam Youlyouz-Marfak, Christophe Le Clorennec, Imen Najjar, Fanny Baran-Marszak, MD-PhD, Nathalie Gachard, MD, Liliane Remenieras, MD, Arnaud Jaccard, MD, Georg W. Bornkamm, Remi Fagard, Jean Feuillard
Journal: Blood
Blood (2005) 106 (11): 4384.
https://doi.org/10.1182/blood.V106.11.4384.4384
Published: 2005